Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanfeng Wang

Showing results (591-600 of 601) with videos related to

Pageof 61
Sort By:
The Review of Scientific Instruments|October 4, 2023
A neutron beam monitor based on ceramic gas electron multiplier with high spatial resolution for low flux measurementsJinhao Tan, Jianrong Zhou, Lin Zhu, et al.
Blood|June 24, 2005
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutationJason Gotlib, Caroline Berubé, Joseph D Growney, et al.
Scientific Reports|April 28, 2021
HDAC2 targeting stabilizes the CoREST complex in renal tubular cells and protects against renal ischemia/reperfusion injuryDavid D Aufhauser, Paul Hernandez, Seth J Concors, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2002
Identification of metabolites of a substance P (neurokinin 1 receptor) antagonist in rat hepatocytes and rat plasmaCornelis E C A Hop, Yanfeng Wang, Sanjeev Kumar, et al.
Medical Image Analysis|May 22, 2024
Fair evaluation of federated learning algorithms for automated breast density classification: The results of the 2022 ACR-NCI-NVIDIA federated learning challengeKendall Schmidt, Benjamin Bearce, Ken Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working GroupJoseph Gibbons, Merrill J Egorin, Ramesh K Ramanathan, et al.
Nucleic Acids Research|May 3, 2021
HDAC3 controls male fertility through enzyme-independent transcriptional regulation at the meiotic exit of spermatogenesisHuiqi Yin, Zhenlong Kang, Yingwen Zhang, et al.
Science Translational Medicine|May 13, 2021
An oral antisense oligonucleotide for PCSK9 inhibitionPeter Gennemark, Katrin Walter, Niclas Clemmensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 20, 2024
Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: A multicenter, retrospective cohort studyZhiyong Guo, Yao Liu, Qi Ling, et al.
Pageof 61

Showing results (591-600 of 601) with videos related to

Sort By:
Pageof 61
The Review of Scientific Instruments|October 4, 2023
A neutron beam monitor based on ceramic gas electron multiplier with high spatial resolution for low flux measurementsJinhao Tan, Jianrong Zhou, Lin Zhu, et al.
Blood|June 24, 2005
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutationJason Gotlib, Caroline Berubé, Joseph D Growney, et al.
Scientific Reports|April 28, 2021
HDAC2 targeting stabilizes the CoREST complex in renal tubular cells and protects against renal ischemia/reperfusion injuryDavid D Aufhauser, Paul Hernandez, Seth J Concors, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2002
Identification of metabolites of a substance P (neurokinin 1 receptor) antagonist in rat hepatocytes and rat plasmaCornelis E C A Hop, Yanfeng Wang, Sanjeev Kumar, et al.
Medical Image Analysis|May 22, 2024
Fair evaluation of federated learning algorithms for automated breast density classification: The results of the 2022 ACR-NCI-NVIDIA federated learning challengeKendall Schmidt, Benjamin Bearce, Ken Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working GroupJoseph Gibbons, Merrill J Egorin, Ramesh K Ramanathan, et al.
Nucleic Acids Research|May 3, 2021
HDAC3 controls male fertility through enzyme-independent transcriptional regulation at the meiotic exit of spermatogenesisHuiqi Yin, Zhenlong Kang, Yingwen Zhang, et al.
Science Translational Medicine|May 13, 2021
An oral antisense oligonucleotide for PCSK9 inhibitionPeter Gennemark, Katrin Walter, Niclas Clemmensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 20, 2024
Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: A multicenter, retrospective cohort studyZhiyong Guo, Yao Liu, Qi Ling, et al.
Pageof 61